Abstract:Mitochondrial dysfunction is a central contributor to the development of β‐cell failure and Type 2 Diabetes (T2D). Succinate dehydrogenase subunit B (SDHB) is a key component of the Succinate Dehydrogenase (SDH) protein complex that strongly impacts mitochondrial function via 1) oxidation of succinate to fumarate in the TCA cycle and 2) electron transfer in the electron transport chain as Complex II. Loss of SDH activity has been observed in diabetic β‐cells (humans and rodents); however, the relevance of this observation to diabetes pathogenesis remains poorly understood. Consistent with prior work, we found reduced SDHB expression in the pancreatic islets of human diabetics. To investigate the links between mitochondrial dysfunction, β‐cell failure and diabetes, we generated mice with a β‐cell‐specific knockout of SDHB (SDHB β KO ). We found that SDHB β KO mice develop early onset diabetes. At 5 weeks, prediabetic SDHB β KO mice demonstrate mildly elevated glucose levels with low insulin levels and normal insulin sensitivity. These in vivo findings were confirmed by a reduction in glucose‐stimulated insulin secretion in SDHB β KO islets. Furthermore, glucose‐induced β‐cell replication was impaired in SDHB β KO mice; consistent with impaired adaptive β‐cell expansion. Given the prominent role of glucose metabolism in controlling β‐cell insulin secretion and replication, we assessed the mitochondrial bioenergetics by Seahorse Assay and found that basal and glucose‐stimulated respiration were significantly reduced in SDHB β KO islets. Notably, loss of SDH is expected to increase succinate accumulation and promote protein succinylation, a recently described bulky post‐translational modification. Indeed, SDHB β KO islets demonstrated a dramatic increase in succinate levels (16‐fold) and protein succinylation (6‐fold), providing a potential mechanism for global mitochondrial dysfunction. Accordingly, expression of the desuccinylation enzyme, Sirt5, was increased in SDHB β KO islets. Metabolomics by mass spectrometry and transcriptomics by high‐throughput RNA sequencing revealed significantly altered mitochondrial metabolism. Finally, protein succinylation levels were increased in islets of diabetic db/db mice indicating lysine‐succinylation may be characteristic of diabetes. Taken together, these results demonstrate a surprisingly necessary role for the SDH complex in β‐cell function and introduce a pathogenic mechanism of diabetes based upon β‐cell metabolic dysfunction. Support or Funding Information Stanford Diabetes Research Center (SRDC) Pilot & Feasibility Grants Program (P30DK116074), Endocrinology Training grant (T32DK007217) and Child Health Research Institute at Stanford (UL1TR001085)

Succinate dehydrogenase is essential for epigenetic and metabolic homeostasis in hearts

Succinyl-CoA-based energy metabolism dysfunction in chronic heart failure

Genetic, epigenetic and biochemical regulation of succinate dehydrogenase function

Cardiac disruption of SDHAF4-mediated mitochondrial complex II assembly promotes dilated cardiomyopathy

DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure

Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation

Mitochondrial Dysfunction Promotes Diabetes via A Previously Unrecognized Mechanism: Protein Succinylation

Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis

Succinate Dehydrogenase and Human Disease: Novel Insights into a Well-Known Enzyme

β-Cell Succinate Dehydrogenase Deficiency Triggers Metabolic Dysfunction and Insulinopenic Diabetes

Succinate dehydrogenase–complex II regulates skeletal muscle cellular respiration and contractility but not muscle mass in genetically induced pulmonary emphysema

Pyruvate transamination and NAD biosynthesis enable proliferation of succinate dehydrogenase-deficient cells by supporting aerobic glycolysis

Loss of SDHB Reprograms Energy Metabolisms and Inhibits High Fat Diet Induced Metabolic Syndromes

Metabolic Substrates, Histone Modifications, and Heart Failure.

Abstract 9328: Sirt5 Deficiency Promotes Metabolic Reprogramming to Aggravate Cardiac Fibrosis

Abstract 075: Ketone Bodies Rescue Mitochondrial Dysfunction And Improve Maladaptive Epigenetic Remodeling In Heart Failure

Ketone Bodies Rescue Mitochondrial Dysfunction Via Epigenetic Remodeling

Exogenous hydrogen sulfide attenuates the development of diabetic cardiomyopathy via the FoxO1 pathway.

Succinate dehydrogenase complex subunit C: Role in cellular physiology and disease

Mitochondrial SENP2 Regulates the Assembly of SDH Complex under Metabolic Stress

SIRT5-Related Desuccinylation Modification Contributes to Quercetin-Induced Protection against Heart Failure and High-Glucose-Prompted Cardiomyocytes Injured through Regulation of Mitochondrial Quality Surveillance